Results 131 to 140 of about 370,587 (208)

G12 mutations rewire allosteric communication at the Ras-RalGDS interface. [PDF]

Biophys J
Demirbas E, Jang H, Kosoglu K, Nussinov R, Gursoy A, Keskin O.   +5 more
europepmc   +1 more source

SDC4 silencing promotes cell cycle arrest at the restriction point (R point) in anoikis-resistant endothelial cells. [PDF]

Cytotechnology
Ferreira BZF, Pereira DMC, Onyeisi JOS, Machado RS, Tamura RE, Nader HB, Lopes CC.   +6 more
europepmc   +1 more source

Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases. [PDF]

Mol Cancer Ther
Carta L, Hutcheson R, Bigarella CL, Zhang S, Davis SA, Rudolph MJ, Reynolds CH, Quick M, Williams TM, Schmertzler M, Hadari YR.   +10 more
europepmc   +1 more source

K-RAS Protein Vaccine [PDF]

, 2020
openaire   +1 more source

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia. [PDF]

Ann Hematol
Yuan R, Xie Y, Miron PM, Higgins AW, Hutchinson L, Cerny J, Patel SA.   +6 more
europepmc   +1 more source

Ras-Interacting Protein 1 [PDF]

, 2020
openaire   +1 more source

Hh and EGFR-Ras signaling promote distinct steps of tumor progression in the Drosophila follicle epithelium. [PDF]

Nat Commun
Anschütz S, Müller H, Schubert A, Peralta JM, Nystul TG, Rust K.   +5 more
europepmc   +1 more source

Key Considerations for Targeting <i>KRAS</i> in Pancreatic Cancer: Potential Impact on the Treatment Paradigm. [PDF]

Drug Des Devel Ther
Eslinger C, Sonbol MB, George B, Babiker H, Borad MJ, Bekaii-Saab TS.   +5 more
europepmc   +1 more source

Impact of Co-Mutations and Genetic Variations on Malignancy Risk in RAS-Positive Indeterminate Thyroid Nodules: an Institutional Experience. [PDF]

Endocr Pathol
Wong LQ, Baloch ZW.
europepmc   +1 more source

Heart Failure: Epidemiology, Pathophysiology, and Management. [PDF]

MedComm (2020)
Fan Y, Yang Z, Li Q, Sun M, Pu Y, Zhao K, Bao Y, Wang X, Mao J, Zhao Z.   +9 more
europepmc   +1 more source